Marco Maria Brughera - Net Worth and Insider Trading
Marco Maria Brughera Net Worth
The estimated net worth of Marco Maria Brughera is at least $39 dollars as of 2024-11-10. Marco Maria Brughera is the Director of Soligenix Inc and owns about 11 shares of Soligenix Inc (SNGX) stock worth over $39. Details can be seen in Marco Maria Brughera's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Marco Maria Brughera has not made any transactions after 2016-12-16 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Marco Maria Brughera
Marco Maria Brughera Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Marco Maria Brughera owns 2 companies in total, including Fennec Pharmaceuticals Inc (FENC) , and Soligenix Inc (SNGX) .
Click here to see the complete history of Marco Maria Brughera’s form 4 insider trades.
Insider Ownership Summary of Marco Maria Brughera
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
FENC | Fennec Pharmaceuticals Inc | 2020-08-13 | director |
SNGX | Soligenix Inc | 2016-12-16 | director |
Marco Maria Brughera Latest Holdings Summary
Marco Maria Brughera currently owns a total of 1 stock. Marco Maria Brughera owns 11 shares of Soligenix Inc (SNGX) as of December 16, 2016, with a value of $39.
Latest Holdings of Marco Maria Brughera
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
SNGX | Soligenix Inc | 2016-12-16 | 11 | 3.50 | 39 |
Holding Weightings of Marco Maria Brughera
Marco Maria Brughera Form 4 Trading Tracker
According to the SEC Form 4 filings, Marco Maria Brughera has made a total of 0 transactions in Soligenix Inc (SNGX) over the past 5 years. The most-recent trade in Soligenix Inc is the acquisition of 8 shares on December 16, 2016, which cost Marco Maria Brughera around $6,320.
Insider Trading History of Marco Maria Brughera
- 1
Marco Maria Brughera Trading Performance
GuruFocus tracks the stock performance after each of Marco Maria Brughera's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Marco Maria Brughera is 22.13%. GuruFocus also compares Marco Maria Brughera's trading performance to market benchmark return within the same time period. The performance of stocks bought by Marco Maria Brughera within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Marco Maria Brughera's insider trading performs compared to the benchmark.
Performance of Marco Maria Brughera
Marco Maria Brughera Ownership Network
Ownership Network List of Marco Maria Brughera
Ownership Network Relation of Marco Maria Brughera
Marco Maria Brughera Owned Company Details
What does Fennec Pharmaceuticals Inc do?
Who are the key executives at Fennec Pharmaceuticals Inc?
Marco Maria Brughera is the director of Fennec Pharmaceuticals Inc. Other key executives at Fennec Pharmaceuticals Inc include director & Chief Executive Officer Rosty Raykov , Chief Financial Officer Robert Andrade , and Chief Commercial Officer Shubh Goel .
Fennec Pharmaceuticals Inc (FENC) Insider Trades Summary
Over the past 18 months, Marco Maria Brughera made no insider transaction in Fennec Pharmaceuticals Inc (FENC). Other recent insider transactions involving Fennec Pharmaceuticals Inc (FENC) include a net sale of 174,884 shares made by Rosty Raykov , a net sale of 18,586 shares made by Chris A Rallis , and a net sale of 82,950 shares made by Robert Andrade .
In summary, during the past 3 months, insiders sold 8,699 shares of Fennec Pharmaceuticals Inc (FENC) in total and bought 0 shares, with a net sale of 8,699 shares. During the past 18 months, 498,641 shares of Fennec Pharmaceuticals Inc (FENC) were sold and 0 shares were bought by its insiders, resulting in a net sale of 498,641 shares.
Fennec Pharmaceuticals Inc (FENC)'s detailed insider trading history can be found in Insider Trading Tracker table.
Fennec Pharmaceuticals Inc Insider Transactions
Marco Maria Brughera Mailing Address
Above is the net worth, insider trading, and ownership report for Marco Maria Brughera. You might contact Marco Maria Brughera via mailing address: Viale Stefini 14, Milano L6 00000.